Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
Bevacizumab injection (HCPCS Q2024) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved July 3, 2026 , from http://ppman.hank.ai/transparency/procedure/Q2024/by-state?code_type=HCPCS
“Bevacizumab injection (HCPCS Q2024) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/Q2024/by-state?code_type=HCPCS. Accessed
July 3, 2026 .
“Bevacizumab injection (HCPCS Q2024) by State,” HANK Price Transparency ,
accessed July 3, 2026 ,
http://ppman.hank.ai/transparency/procedure/Q2024/by-state?code_type=HCPCS.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
HCPCS · across United States
Q2024 — Bevacizumab Injection
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$50
National median
$4 – $255,584
IQR (p25 – p75)
7
hospitals filing
5
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for Q2024 (HCPCS), with interquartile range
State Median p25 p75
TX $511,072 $511,072 $511,072
PA $50 $50 $50
OH $4 $4 $4
LA $2 $2 $2